Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5701426 | Journal of Thoracic Oncology | 2017 | 29 Pages |
Abstract
The high positive LR of sputum CA-FISH indicates that it could be a useful adjunct to low-dose computed tomography for lung cancer in high-risk settings. For screening, however, its low positive LR limits clinical utility. Prospective assessment of CA-FISH in the incidentally identified indeterminate nodule setting is ongoing in the Colorado Pulmonary Nodule Biomarker Trial.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Anna E. PhD, Severine BS, William J. MS, Heather BS, Daniel MD, Kavita MD, Stephen MD, PhD, Shannon BA, Jill M. PhD, Wilbur A. PhD, York MD, Holly J. MSPH, PhD, Marileila PhD,